Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial

Bo Noordman, MGE Verdam, Sjoerd Lagarde, J (Joël) Shapiro, M Hulshof, MIV Henegouwen, Bas Wijnhoven, GAP Nieuwenhuijzen, JJ Bonenkamp, MA Cuesta, JTM Plukker, EJS Bilgen, Ewout Steyerberg, Ate van der Gaast, MAG Sprangers, Jan van Lanschot

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)445-451
Number of pages7
JournalAnnals of Oncology
Volume29
Issue number2
DOIs
Publication statusPublished - 2018

Cite this